What does Codexis, Inc. do?
Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia,…
What is Codexis, Inc.'s P/E and P/B ratio?
Codexis, Inc. has a P/E ratio of -4.0 and a P/B ratio of 4.35.
What is Codexis, Inc.'s debt-to-equity ratio?
Codexis, Inc. has a debt-to-equity ratio of 2.20.
How much does Codexis, Inc. owe compared with what it owns?
Codexis, Inc. owes $0.73 for every $1 it owns (balance sheet Jun 2026), which is moderate.
What is Codexis, Inc.'s Positivity rank?
Codexis, Inc. is ranked #5,342 of 6,774 companies globally and #2,888 of 4,000 in United States on PositoAI, with a Positivity Score of 17,704.
Does Codexis, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Codexis, Inc..
Where can I read the latest news about Codexis, Inc.?
Recent headlines about Codexis, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Codexis, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Codexis, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.